Si mostrano 100 riferimenti a partire da 1 |
Per ulteriori informazioni selezionare i riferimenti di interesse.
Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
Three thiadiazinone derivatives, EMD 60417, EMD 66430, and EMD 66398, withclass III antiarrhythmic activity but different electrophysiologic profiles
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
Interaction of azimilide with neurohumoral and channel receptors
BIOCHEMICAL PHARMACOLOGY
Comparison of QT dispersion during atrial fibrillation and sinus rhythm inthe same patients, at normal and prolonged ventricular repolarization
EUROPACE
Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: A clinical trial
CLINICAL CARDIOLOGY
Effect of GLG-V-13, a Class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes
LIFE SCIENCES
Electrophysiological effects of ibutilide on the delayed rectifier K+ current in rabbit sinoatrial and atrioventricular node cells
EUROPEAN JOURNAL OF PHARMACOLOGY
Electrophysiological aspects of changes in heart rate
HEART RATE AS A DETERMINANT OF CARDIAC FUNCTION
Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs
HEART RATE AS A DETERMINANT OF CARDIAC FUNCTION
Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
Effects of the I-kr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study
CARDIOVASCULAR DRUGS AND THERAPY
Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing
BIOPHARMACEUTICS & DRUG DISPOSITION
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Mechanism of antiarrhythmic action of nibentan on experimental model of vagotonic atrial fibrillation in the canine heart
KARDIOLOGIYA
Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine purkinje fiber action potentials - Implications for prevention of proarrhythmia induced by class III agents
JAPANESE HEART JOURNAL
Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells
BRITISH JOURNAL OF PHARMACOLOGY
THE HEART RATE-CORRECTED QT INTERVAL OF CONSCIOUS BEAGLE DOGS - A FORMULA BASED ON ANALYSIS OF COVARIANCE
TOXICOLOGICAL SCIENCES
ELECTROPHYSIOLOGICAL ASPECTS OF CHANGES IN HEART-RATE
Basic research in cardiology
RATE-DEPENDENCE OF ANTIARRHYTHMIC AND PROARRHYTHMIC PROPERTIES OF CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS
Basic research in cardiology
SHORT-TERM MYOCARDIAL UPTAKE OF D-SOTALOL AND L-SOTALOL IN HUMANS - RELATION TO HEMODYNAMIC AND ELECTROPHYSIOLOGIC EFFECTS
Journal of cardiovascular pharmacology
KCB-328 - A NOVEL CLASS-III ANTIARRHYTHMIC AGENT WITH LITTLE REVERSE FREQUENCY-DEPENDENCE IN ISOLATED GUINEA-PIG MYOCARDIUM
Journal of cardiovascular pharmacology
ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION
Journal of cardiovascular pharmacology
COMPARISON OF SOTALOL AND METOPROLOL IN THE PREVENTION OF ATRIAL-FIBRILLATION AFTER CORONARY-ARTERY BYPASS-SURGERY
Journal of cardiovascular pharmacology
A HIGH-AFFINITY BINDING-SITE FOR [H-3]-DOFETILIDE ON HUMAN-LEUKOCYTES
Journal of Molecular and Cellular Cardiology
DISCORDANT PROLONGATION OF THE REFRACTORY PERIOD AND REPOLARIZATION TIME BY A CLASS-III AGENT, E4031, IN THE HEALING PHASE OF MYOCARDIAL-INFARCTION
Japanese Heart Journal
ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS MS-551, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, ON HUMAN ATRIUM AND VENTRICLE
Japanese Heart Journal
COMPARATIVE ELECTROPHYSIOLOGIC FINDINGS BETWEEN RESPONDERS AND NONRESPONDERS TO CLASS-III ANTIARRHYTHMIC DRUGS AMONG PATIENTS WITH VENTRICULAR TACHYARRHYTHMIA
Japanese Heart Journal
COMBINED POTASSIUM AND CALCIUM-CHANNEL ANTAGONISTIC ACTIVITIES AS A BASIS FOR NEUTRAL FREQUENCY-DEPENDENT INCREASE IN ACTION-POTENTIAL DURATION - COMPARISON BETWEEN BRL-32872 AND AZIMILIDE
Cardiovascular Research
MS-551 AND KCB-328, 2 CLASS-III DRUGS AGGRAVATED ADRENALINE-INDUCED ARRHYTHMIAS
British Journal of Pharmacology
EARLY AFTERDEPOLARIZATIONS PRODUCED BY D,L-SOTALOL AND CLOFILIUM
Journal of cardiovascular electrophysiology
COMPARISON OF THE RATE-DEPENDENT PROPERTIES OF THE CLASS-III ANTIARRHYTHMIC AGENTS AZIMILIDE (NE-10064) AND E-4031 - CONSIDERATIONS ON THE MECHANISM OF REVERSE RATE-DEPENDENT ACTION-POTENTIAL PROLONGATION
Journal of cardiovascular electrophysiology
AZIMILIDE (NE-10064) CAN PROLONG OR SHORTEN THE ACTION-POTENTIAL DURATION IN CANINE VENTRICULAR MYOCYTES - DEPENDENCE ON BLOCKADE OF K, CA,AND NA CHANNELS
Journal of cardiovascular electrophysiology
DIFFERENTIAL EFFECT OF BETA-ADRENERGIC STIMULATION ON THE FREQUENCY-DEPENDENT ELECTROPHYSIOLOGIC ACTIONS OF THE NEW CLASS-III ANTIARRHYTHMICS DOFETILIDE, AMBASILIDE, AND CHROMANOL 293B
Journal of cardiovascular electrophysiology
EFFECTS OF AZIMILIDE AND D,L-SOTALOL ON THE HEART-RATE AND BLOOD-PRESSURE RESPONSE TO ISOPROTERENOL IN ANESTHETIZED RATS
Cardiovascular drugs and therapy
EMERGING CLASS-III ANTIARRHYTHMIC AGENTS - MECHANISM OF ACTION AND PROARRHYTHMIC POTENTIAL
Cardiovascular drugs and therapy
MAGNESIUM SHIFTS VOLTAGE-DEPENDENCE OF ACTIVATION OF DELAYED RECTIFIER I-K IN GUINEA-PIG VENTRICULAR MYOCYTES
American journal of physiology. Heart and circulatory physiology
AMIODARONE - THE EXPANDING ANTIARRHYTHMIC ROLE AND HOW TO FOLLOW A PATIENT ON CHRONIC THERAPY
Clinical cardiology
CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .3. EFFICACY IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS - ARRHYTHMOGENIC EFFECTS
Kardiologia
NIBENTAN INHIBITS THE DELAYED RECTIFIER P OTASSIUM CURRENT IN RAT VENTRICULAR MYOCYTES
Kardiologia
CLOFILIUM-INDUCED BLOCK OF DELAYED RECTIFIER TYPE K-CELLS (AT-1 CELLS)( CURRENT IN ATRIAL TUMOR)
Journal of Molecular and Cellular Cardiology
BIOCATALYTIC SYNTHESIS OF SOME CHIRAL DRUG INTERMEDIATES BY OXIDOREDUCTASES
Journal of the American Oil Chemists' Society
EFFECTS OF AZIMILIDE DIHYDROCHLORIDE ON CIRCUS MOVEMENT ATRIAL-FLUTTER IN THE CANINE STERILE PERICARDITIS MODEL
Journal of cardiovascular electrophysiology
LIDOCAINE AND NISOLDIPINE ATTENUATE ALMAKOLANT-INDUCED DISPERSION OF REPOLARIZATION AND EARLY AFTERDEPOLARIZATIONS IN-VITRO
Journal of cardiovascular electrophysiology
INDIRECT PARASYMPATHOMIMETIC ACTIVITY OF THE CLASS-III ANTIARRHYTHMICSUBSTANCE D L-SOTALOL IN-VITRO - REVERSIBLE INHIBITION OF CHOLINESTERASE ISOENZYMES FROM BLOOD AND THE HUMAN CENTRAL-NERVOUS-SYSTEM/
Pharmacological research
ASSESSMENT OF FREQUENCY DEPENDENCY OF THE CLASS-III EFFECTS OF ALMOKALANT - A STUDY USING PROGRAMMED STIMULATION AND RECORDING OF MONOPHASIC ACTION-POTENTIALS AND VENTRICULAR PACED QT INTERVALS
Cardiovascular drugs and therapy
PRECONDITIONING IS NOT ABOLISHED BY THE DELAYED RECTIFIER K+ BLOCKER DOFETILIDE
American journal of physiology. Heart and circulatory physiology
INHIBITION OF POTASSIUM CURRENTS BY THE ANTIARRHYTHMIC DRUG E4031 IN RAT TASTE RECEPTOR-CELLS
Neuroscience letters
BLOCKADE ON SODIUM, POTASSIUM, AND CALCIUM CHANNELS BY A NEW ANTIARRHYTHMIC AGENT CPU-86017
Drug development research
CHANGES IN ATRIOVENTRICULAR-CONDUCTION PROPERTIES WITH REFRACTORY-PERIOD MODULATION
Journal of cardiovascular pharmacology
CLASS-III ANTIARRHYTHMIC EFFECTS OF LY-190147 ON DEFIBRILLATION THRESHOLD
Journal of cardiovascular pharmacology
COMPARISON OF DIRECT NEGATIVE CHRONOTROPIC AND POSITIVE INOTROPIC EFFECTS OF SEMATILIDE TO THOSE OF E-4031 AND MS-551 AND THE REVERSE FREQUENCY-DEPENDENT PROLONGATION OF CARDIAC REFRACTORINESS OF SEMATILIDE
Journal of cardiovascular pharmacology
ELECTROPHYSIOLOGICAL, RATE-DEPENDENT, AND AUTONOMIC EFFECTS OF THE CLASS-III ANTIARRHYTHMIC ALMOKALANT AFTER MYOCARDIAL-INFARCTION IN THE PIG
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
USE OF INTRAVENOUS DOFETILIDE IN ATRIAL-FLUTTER WITH HEMODYNAMIC INSTABILITY
Japanese Circulation Journal
EFFECTS OF THE CLASS-III ANTIARRHYTHMIC DRUG AMBASILIDE ON OUTWARD CURRENTS IN HUMAN ATRIAL MYOCYTES
Naunyn-Schmiedeberg's archives of pharmacology
CLINICAL-STUDY OF NIBENTAN - NEW CLASS-II I ANTIARRHYTHMIC DRUG .2. EFFICACY IN PATIENTS WITH SUPRAVENTRICULAR ARRHYTHMIAS
Kardiologia
ELECTROPHYSIOLOGICAL AND ANTIARRHYTHMIC E FFECTS OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYARRHYTHMIAS
Kardiologia
[H-3] DOFETILIDE BINDING - BIOLOGICAL MODELS THAT MANIFEST SOLELY THEHIGH OR THE LAW AFFINITY BINDING-SITE
Journal of Molecular and Cellular Cardiology
CLASS-III ANTIARRHYTHMIC DRUGS BLOCK HERG, A HUMAN CARDIAC DELAYED RECTIFIER K- OPEN-CHANNEL BLOCK BY METHANESULFONANILIDES( CHANNEL )
Circulation research
I-K INDEPENDENT CLASS-III ACTIONS OF MS-551 COMPARED WITH SEMATILIDE AND DOFETILIDE DURING REPERFUSION IN ANESTHETIZED RATS
British Journal of Pharmacology
EFFECTS OF CLASS-III ANTIARRHYTHMIC DRUGS ON THE NA-ACTIVATED K+ CHANNELS IN GUINEA-PIG VENTRICULAR CELLS()
British Journal of Pharmacology
CISAPRIDE-INDUCED PROLONGATION OF CARDIAC ACTION-POTENTIAL AND EARLY AFTERDEPOLARIZATIONS IN RABBIT PURKINJE-FIBERS
British Journal of Pharmacology
EFFECTS OF OPTICAL ENANTIOMERS CK-4000(S) AND CK4001(R) ON DEFIBRILLATION AND ENHANCEMENT OF SHOCK-INDUCED EXTENSION OF ACTION-POTENTIAL DURATION
Journal of cardiovascular electrophysiology
PARENTERAL ANTIARRHYTHMIC DRUG-THERAPY IN VENTRICULAR-TACHYCARDIA VENTRICULAR-FIBRILLATION - EVOLVING ROLE OF CLASS-III AGENTS - FOCUS ON AMIODARONE
Journal of cardiovascular electrophysiology
EFFECTS OF CHANNEL MODULATION AND PH ON I-SK INHIBITION BY THE NOVEL CLASS-III ANTIARRHYTHMIC AZIMILIDE(NE-10064)
European journal of pharmacology. Molecular pharmacology section
THE ROLE OF THE DELAYED RECTIFIER K+ CURRENT IN THE PACEMAKER ACTIVITY IN RABBIT SINOATRIAL NODE CELLS
Heart and vessels
A RAPIDLY ACTIVATING DELAYED RECTIFIER K+ CHANNEL IN RABBIT SINOATRIAL NODE CELLS
American journal of physiology. Heart and circulatory physiology
ROLE OF RAPIDLY ACTIVATING DELAYED RECTIFIER K+ CURRENT IN SINOATRIALNODE PACEMAKER ACTIVITY
American journal of physiology. Heart and circulatory physiology
EFFECTS OF DOFETILIDE ON ELECTRICAL DISPERSION AND ARRHYTHMIAS IN POST-INFARCTED ANESTHETIZED DOGS
Basic research in cardiology
CELLULAR ELECTROPHYSIOLOGICAL EFFECTS OF MS-551, A NEW CLASS-III ANTIARRHYTHMIC AGENT
Drug development research
SELECTIVE I-K BLOCKER ALMOKALANT EXHIBITS CLASS III-SPECIFIC EFFECTS ON THE REPOLARIZATION AND REFRACTORINESS OF THE HUMAN HEART - A STUDY OF HEALTHY-VOLUNTEERS USING RIGHT-VENTRICULAR MONOPHASIC ACTION-POTENTIAL RECORDINGS
Journal of cardiovascular pharmacology
EFFECT OF ALMOKALANT, A SELECTIVE POTASSIUM CHANNEL BLOCKER, ON THE TERMINATION AND INDUCIBILITY OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS - A STUDY IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA
Journal of cardiovascular pharmacology
TOLERANCE AND EFFECTS OF ALMOKALANT, A NEW SELECTIVE I-K BLOCKING-AGENT, ON VENTRICULAR REPOLARIZATION AND ON SINOATRIAL AND ATRIOVENTRICULAR NODAL FUNCTION IN THE HEART - A STUDY IN HEALTHY, MALE-VOLUNTEERS UTILIZING TRANSESOPHAGEAL ATRIAL STIMULATION
Journal of cardiovascular pharmacology
MS-551 PROTECTS AGAINST VENTRICULAR-FIBRILLATION IN A CHRONIC CANINE MODEL OF SUDDEN CARDIAC DEATH
Journal of cardiovascular pharmacology
ELECTROPHYSIOLOGICAL EFFECTS OF MS-551 IN HUMANS - A CLASS-III ANTIARRHYTHMIC AGENT
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
INTERACTION OF CLASS-III ANTIARRHYTHMIC DRUGS WITH MUSCARINIC M(2) AND M(3) RECEPTORS - RADIOLIGAND BINDING AND FUNCTIONAL-STUDIES
Naunyn-Schmiedeberg's archives of pharmacology
CLINICAL INVESTIGATION OF A NEW CLASS-III ANTIARRHYTHMIC DRUG NIBENTAN .1. TOLERABILITY STUDY
Kardiologia
PILOT EXPERIENCE IN INVESTIGATION OF ELEC TROPHYSIOLOGICAL AND ANTIARRHYTHMIC EFFECTS OF NIBENTAN IN PATIENTS WITH PAROXYSMAL TACHYARRHYTHMIAS
Kardiologia
ELECTROPHYSIOLOGICAL ASPECTS OF CARDIAC A CTION OF A NEW ANTIARRHYTHMIC DRUG NIBENTAN (EXPERIMENTAL-STUDY)
Kardiologia
EFFECTS OF SEMATILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, ON ACTION-POTENTIAL IN GUINEA-PIG ATRIUM
Japanese Journal of Pharmacology
EFFECTS OF THE NEW CLASS-III ANTIARRHYTHMIC DRUG MS-551 AND D-SOTALOLON CANINE CORONARY LIGATION-REPERFUSION VENTRICULAR ARRHYTHMIAS
Japanese Journal of Pharmacology
SR-33589, A NEW AMIODARONE-LIKE ANTIARRHYTHMIC AGENT - ANTI-ADRENOCEPTOR ACTIVITY IN ANESTHETIZED AND CONSCIOUS DOGS
European journal of pharmacology
CLONED HUMAN INWARD RECTIFIER K-III METHANESULFONANILIDES( CHANNEL ASA TARGET FOR CLASS)
Circulation research
EFFECTS OF DELAYED RECTIFIER CURRENT BLOCKADE BY E-4031 ON IMPULSE GENERATION IN SINGLE SINOATRIAL NODAL MYOCYTES OF THE RABBIT
Circulation research
SELECTIVE BLOCK OF DELAYED RECTIFYING POTASSIUM CURRENT IN THE RABBITSINOATRIAL NODE BY A NOVEL CLASS-III ANTIARRHYTHMIC AGENT MS-551
Heart and vessels
DETERMINATION OF L-691,121, A NEW CLASS-III ANTIARRHYTHMIC, AND ITS PRINCIPAL METABOLITE IN PLASMA BY DIFFERENTIAL RADIOIMMUNOASSAY
Journal of pharmaceutical and biomedical analysis
ATRIAL-FLUTTER CAN BE TERMINATED BY A CLASS-III ANTIARRHYTHMIC DRUG BUT NOT BY A CLASS-IC DRUG
European heart journal
COMPARATIVE EFFECTS OF INCREASED EXTRACELLULAR POTASSIUM AND PACING FREQUENCY ON THE CLASS-III ACTIVITIES OF METHANESULFONANILIDE I-KR BLOCKERS DOFETILIDE, D-SOTALOL, E-4031, AND MK-499
Journal of cardiovascular pharmacology
COMPARISON OF THE CARDIAC ELECTROPHYSIOLOGIC EFFECTS OF NE-10064 WITHSOTALOL AND E-4031 AND THEIR MODIFICATION BY SIMULATED ISCHEMIA
Journal of cardiovascular pharmacology
EFFECTS OF MS-551, A NEW CLASS-III ANTIARRHYTHMIC DRUG, ON PROGRAMMEDSTIMULATION-INDUCED VENTRICULAR ARRHYTHMIAS, ELECTROPHYSIOLOGY, AND HEMODYNAMICS IN A CANINE MYOCARDIAL-INFARCTION MODEL
Journal of cardiovascular pharmacology
ANTIARRHYTHMIC AGENT, MS-551, PROTECTS AGAINST PINACIDIL PLUS HYPOXIA-INDUCED VENTRICULAR-FIBRILLATION IN LANGENDORFF-PERFUSED RABBIT ISOLATED HEART
Journal of cardiovascular pharmacology
FREQUENCY-DEPENDENT EFFECTS OF E-4031, ALMOKALANT, DOFETILIDE AND TEDISAMIL ON ACTION-POTENTIAL DURATION - NO EVIDENCE FOR REVERSE USE-DEPENDENT BLOCK
Naunyn-Schmiedeberg's archives of pharmacology
BLOCKADE OF HUMAN I-SK CHANNELS EXPRESSED IN XENOPUS OOCYTES BY THE NOVEL CLASS-III ANTIARRHYTHMIC NE-10064
European journal of pharmacology
KETANSERIN INHIBITS DEPOLARIZATION-ACTIVATED OUTWARD POTASSIUM CURRENT IN RAT VENTRICULAR MYOCYTES
Circulation research
ANTIFIBRILLATORY EFFECTS OF CLOFILIUM IN THE RABBIT ISOLATED HEART
British Journal of Pharmacology
EFFECT OF E-4031, A NEW CLASS-III ANTIARRHYTHMIC DRUG, ON REENTRANT VENTRICULAR ARRHYTHMIAS - COMPARISON WITH CONVENTIONAL CLASS-I DRUGS
Cardiovascular drugs and therapy
MS-551 - PHARMACOLOGICAL PROFILE OF A NOVEL CLASS-III ANTIARRHYTHMIC AGENT
Drug development research
PROARRHYTHMIC EFFECTS OF DPI 201-106 ELICITED WITH PROGRAMMED ELECTRICAL-STIMULATION - A COMPARISON WITH SOTALOL
Journal of cardiovascular pharmacology
PROPRANOLOL UNMASKS CLASS-III LIKE ELECTROPHYSIOLOGICAL PROPERTIES OFNOREPINEPHRINE
Naunyn-Schmiedeberg's archives of pharmacology